The clinical trial, sponsored by the University of Liege, explores the use of virtual reality hypnosis (VRH) as a supportive care intervention for pain management in oncological patients undergoing port-a-cath placement. The study aims to elucidate the neurophysiological mechanisms of dissociation during VRH, potentially positioning VRH as a novel therapeutic tool in oncology. Given the increasing focus on non-pharmacological pain management strategies, successful outcomes could enhance market interest in VRH technologies, particularly in collaboration with industry partners like Oncomfort. The competitive landscape includes other emerging technologies in pain management and psychological interventions, necessitating diligence on existing patents and market positioning. The trial's findings may influence future product development and partnerships in the digital health and therapeutic sectors.